Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
The primary objective of this study is to compare the overall survival (OS) of patients who have received one prior regimen of dacarbazine or temozolomide-based chemotherapy for metastatic malignant melanoma when treated with either tasisulam or paclitaxel.
Critère d'inclusion
- Second Line metastatic melanoma